Papers by Christina Gerlach
Geburtshilfe Und Frauenheilkunde, Nov 1, 2018
Bookmarks Related papers MentionsView impact
Zeitschrift für Palliativmedizin, Aug 1, 2020
Bookmarks Related papers MentionsView impact
Zeitschrift für Palliativmedizin, Aug 1, 2020
Bookmarks Related papers MentionsView impact
Zeitschrift für Palliativmedizin, Aug 1, 2020
Bookmarks Related papers MentionsView impact
Palliative Medicine, 2021
Bookmarks Related papers MentionsView impact
Research Square (Research Square), Feb 28, 2020
Bookmarks Related papers MentionsView impact
Background: The desire to be at home is one of the most important needs of patients with advanced... more Background: The desire to be at home is one of the most important needs of patients with advanced, incurable cancers. However, palliative cancer patients may require inpatient hospital care for medical reasons. Virtual reality (VR) could provide an approximation to the individuals’ home environment. Methods: The project consists of 3 parts. All parts are supported by the patient advisory board. In the 1st part of the project, we interview patients, relatives, and the patient advisory board about their wishes and concerns regarding the project. In the 2nd part of the project, patients are offered to view VR videos of their choice (their home, relatives, others if applicable). Effects and side-effects of the intervention are assessed with validated instruments (MIDOS, MDBF, SSQ, SPES). Diagnosis, treatment adherence, medication, and vegetative functionality is determined from the medical records of the patients. In the 3rd part of the project, the results of the study will be discusse...
Bookmarks Related papers MentionsView impact
Die Onkologie, Mar 13, 2023
Bookmarks Related papers MentionsView impact
Deutsches Arzteblatt International, Apr 10, 2020
Bookmarks Related papers MentionsView impact
Vandenhoeck & Ruprecht eBooks, May 3, 2018
Bookmarks Related papers MentionsView impact
Research Square (Research Square), Mar 11, 2020
Bookmarks Related papers MentionsView impact
Zeitschrift für Palliativmedizin, 2016
Bookmarks Related papers MentionsView impact
Journal of Cancer Research and Clinical Oncology
Purpose Guidelines recommend a structured symptom screening (SC) for especially advanced cancer p... more Purpose Guidelines recommend a structured symptom screening (SC) for especially advanced cancer patients (CPs). The aim of this multicenter German prospective quality assurance project KeSBa (Kennzahl Symptom- und Belastungserfassung) was to gain knowledge on SC procedures in Oncology Centers (OCs) for advanced cancer patients and a first impression on the consequences of SC. Methods The KeSBa project consisted of three phases: pilot, 3 months screening and feedback phase. Participating OCs decided to use either the Minimal Documentation System (MIDOS) or the Integrated Palliative care Outcome Scale (IPOS) and defined the cutoff values for positive screening results. Results Out of 172 certified German OCs, 40 (23%) participated in the KeSBa pilot phase, 29 (16.8%) in the 3 months screening phase using MIDOS (n = 18, 58.6%) or IPOS (n = 11, 41.3%) and in the feedback round. 25/29 performed paper-based screening (86.2%). 2.963 CPs were screened. Results were documented for 1255 (42.2...
Bookmarks Related papers MentionsView impact
Supportive Care in Cancer, Dec 23, 2022
Bookmarks Related papers MentionsView impact
Oncologist, Jun 17, 2021
Bookmarks Related papers MentionsView impact
Onkologe, Sep 29, 2021
Palliativmedizin dient der Verbesserung der Lebensqualität bei unheilbaren Erkrankungen. Die medi... more Palliativmedizin dient der Verbesserung der Lebensqualität bei unheilbaren Erkrankungen. Die medikamentöse Symptomkontrolle spielt dabei eine wichtige Rolle. „Off label use“ bezeichnet den Einsatz von Arzneimitteln außerhalb der Zulassung. Neben der Indikation können Anwendungsdauer, Applikationsweg und Mischung von Substanzen der Grund für einen „off label use“ sein. In der Palliativmedizin und Hospizversorgung ist der „off label use“ verbreitet und wahrscheinlich oft auch unumgänglich. Für die Planung und Durchführung einer Off-label-Therapie sollten neben arzneimittelbezogenen Informationen auch patientenbezogene Aspekte, Aufklärung, Therapieüberwachung und Dokumentation der Therapieeffekte Berücksichtigung finden. Nur so ist eine nach wissenschaftlichem Stand ausreichende, zweckmäßige und wirtschaftliche Therapie mit einem für den Einzelfall angemessenen Nutzen-Risiko-Verhältnis anzubieten. In Ermangelung von Zulassungsstudien kommt der Berichterstattung eine besondere Rolle zu.
Bookmarks Related papers MentionsView impact
Deutsches Arzteblatt International, Jun 10, 2019
Bookmarks Related papers MentionsView impact
Gynakologe, Jun 29, 2018
Bookmarks Related papers MentionsView impact
Heilberufe, Mar 1, 2014
Bookmarks Related papers MentionsView impact
Deutsche Medizinische Wochenschrift, Oct 10, 2012
Bookmarks Related papers MentionsView impact
Uploads
Papers by Christina Gerlach